Risk profile and thromboprophylaxis practices among patients undergoing laparotomy at Moi teaching and referral hospital

Authors

  • Njeri N. Dennis Department of Surgery and Anesthesia, College of Health Sciences, Moi University, Eldoret, Kenya
  • Andrew O. Wandera Department of Surgery and Anesthesia, College of Health Sciences, Moi University, Eldoret, Kenya
  • John T. Simiyu Department of Surgery and Anesthesia, College of Health Sciences, Moi University, Eldoret, Kenya

DOI:

https://doi.org/10.18203/2349-2902.isj20242758

Keywords:

VTE, Thromboprophylaxis, Risk profile

Abstract

Background: Venous thromboembolism (VTE) significantly causes hospital mortality worldwide, with abdominal surgery a risk factor. Venous thromboprophylaxis can reduce VTE risk, but has adverse effects. Local research on risk profile and practice helps individualize thromboprophylaxis and develop local protocols.

Methods: A prospective study was conducted at Moi teaching and referral hospital (MTRH) on adult laparotomy patients. The minimal sample size was 325 patients, using consecutive sampling. DVT was assessed using Well's score perioperatively, 2 weeks and 4 weeks postoperatively. A lower limb Doppler ultrasonography was performed on patients with a score of 2 or greater to rule out DVT.

Results: The mean age of study participants was 38 years, with a 1.5:1 male-to-female ratio. Infection in the abdomen was the main reason for laparotomy. All procedures were open, and 75.4% of individuals had high or moderate VTE risk. Within 72 hours, 82.7% of patients were mobilized. Chemoprophylaxis was limited to enoxaparin post-op. Enoxaparin duration was unstandardized, and MTRH VTE risk categorization chart use was not reported. 3% of individuals received chemoprophylaxis against ACCP guidelines and 12% received enoxaparin despite contraindications. Only 13% and 24% of intermediate and high-risk patients got chemoprophylaxis. No mechanical prophylaxis was used. Symptomatic DVT was 6.8%. Advanced age, Caprini score, and enoxaparin prescription increased symptomatic DVT risk.

Conclusions: Despite increased laparotomies for intra-abdominal infection and middle-aged patients, VTE is common in MTRH patients. Poor VTE risk stratification and MTRH protocol failure led to improper thromboprophylaxis. Prescribers should employ MTRH VTE regimen for proper prophylaxis. Providing prescribers with thromboprophylaxis choices to customize prescriptions.

 

References

Fanikos J, Piazza G, Zayaruzny M, Goldhaber SZ. Long-term complications of medical patients with hospital-acquired venous thromboembolism. Thromb Haemost. 2009;102(4):688-93.

MoH-Kenya DONCD. Kenya National Guidelines for Cardiovascular Diseases Management. 2018;8-238.

Ogeng'o JA, Gatonga P, Olabu BA. Cardiovascular causes of death in an east African country: An autopsy study. Cardiol J. 2011;18(1):67-72.

Ogeng’o JA, Obimbo MM, Olabu BO, Gatonga PM, Ong’era D. Pulmonary thromboembolism in an East African tertiary referral hospital. J Thromb Thrombolysis. 2011;32(3):386-91.

Heit JA. Risk factors for venous thromboembolism. Clin Chest Med. 2003;24(1):1-12.

Obi AT, Pannucci CJ, Nackashi A, Newaj A, Rafael A, Vinita B, et al. Validation of the caprini venous thromboembolism risk assessment model in critically ill surgical patients. JAMA Surg. 2015;150(10):941-8.

Kesieme EB, Arekhandia BJ, Inuwa IM. Knowledge and practice of prophylaxis of deep venous thrombosis: A survey among Nigerian surgeons. Niger J Clin Pract. 2016;19(2):170-4.

Muchunu PM. Assessment of venous thromboembolism risk and prohylaxis practices among elective surgical patients at Kenyatta national hospital. University of Nairobi. 2018.

Cushman M, Barnes GD, Creager MA, Jose AD, Peter KH, Kellie RM, et al. Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis. Res Pract Thromb Haemost. 2020;4(5):714-21.

Bulger CM, Jacobs C, Patel NH. Epidemiology of acute deep vein thrombosis. Tech Vasc Interv Radiol. 2004;7(2):50-4.

Osime U, Lawrie J, Lawrie H. Post-operative deep vein thrombosis incidence in Nigerians. Niger Med J J Niger Med Assoc. 1976;6(1):26-28.

Balachandran R, Jensen KK, Burcharth J, Ekeloef S, Schack AE, Gögenur I. Incidence of Venous Thromboembolism Following Major Emergency Abdominal Surgery. World J Surg. 2020;44(3):704-10.

Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251(2):344-50.

Mittal P, Heuft T, Richter DF, Wiedner M. Venous Thromboembolism (VTE) Prophylaxis After Abdominoplasty and Liposuction: A Review of the Literature. Aesthetic Plast Surg. 2019;44(2):473-82.

Lobastov K, Barinov V, Schastlivtsev I, Laberko L, Rodoman G, Boyarintsev V. Validation of the Caprini risk assessment model for venous thromboembolism in high-risk surgical patients in the background of standard prophylaxis. J Vasc Surg Venous Lymphat Disord. 2016;4(2):153-60.

Morris RJ, Woodcock JP. Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis? A systematic review of direct clinical comparisons. Ann Surg. 2010;251(3):393-6.

Sachdeva A, Dalton M, Amaragiri S V, Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2010;(7):10.

Ortman ML, Hecht TEH. Prevention of Venous Thromboembolism in the Surgical Patient. Evid-Based Med Consult. 2007;151-222.

Abukhalil AD, Nasser A, Khader H, Miral A, Raed M, Al-Shami N, et al. VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines. Vasc Health Risk Manag. 2022;18:701.

Henke PK, Kahn SR, Pannucci CJ, Eric AS, Natalie SE, Alok AK, et al. Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement from the American Heart Association. Circulation. 2020;141(24):E914-31.

Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. The Lancet. 2008;371(9610):387-94.

Sakon M, Maehara Y, Yoshikawa H, Akaza H. Incidence of venous thromboembolism following major abdominal surgery: A multi-center, prospective epidemiological study in Japan. J Thrombosis Haemostasis. 2006;4(3):581-6.

Muleledhu AL, Galukande M, Makobore P, Mwambu T, Ameda F, Kiguli-Malwadde E. Deep venous thrombosis after major abdominal surgery in a Ugandan hospital: a prospective study. Int J Emerg Med. 2013;6:43.

Geerts WH, Pineo GF, Heit JA, Bergquist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3):338S-400S.

Muchunu PM. Assessment of venous thromboembolism risk and prohylaxis practices among elective surgical patients at Kenyatta national hospital. University of Nairobi. 2018.

Ndeleva BM, Lakati KC. Graduated compression therapy usage among surgeons in the COSECSA region: A cross-sectional study. East Central Afr J Surg. 2018;23(1):11.

Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2012;141(2):e227S.

Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A,et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Eng J Med. 2002;346(13):975-80.

Ho KM, Tan JA. Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients. Circulation. 2013;128(9):1003-20.

O’Donnell M, Weitz JI. Thromboprophylaxis in surgical patients. Can J Surg. 2003;46(2):129-35.

Danwang C, Temgoua MN, Agbor VN, Tankeu AT, Noubiap JJ. Epidemiology of venous thromboembolism in Africa: a systematic review. J Thrombosis Haemostasis. 2017;15(9):1770-81.

Pannucci CJ, Laird S, Dimick JB, Campbell DA, Henke PK. A validated risk model to predict 90-day vte events in postsurgical patients. Chest. 2014;145(3):567-73.

Kakkar AK, Davidson BL, Haas SK, Büller HR, Levine M, Arcelus JI, et al. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thrombosis Haemostasis. 2010;2(2):221-7.

Somasundram K, Neville JJ, Sinha Y, Agarwal T, Raje D, Sinha A, Sheth H. The weekend effect – How can it be mitigated? Introduction of a consultant-delivered emergency general surgical service. Annals of Medicine and Surg. 2020;57:315-20.

Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, et al. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020;21(1):73-9.

Jörgren F, Johansson R, Damber L, Lindmark G. Validity of the Swedish Rectal Cancer Registry for patients treated with major abdominal surgery between 1995 and 1997. Acta Oncol. 2013;52(8):1707-14.

Nguyen NT, Hinojosa MW, Fayad C, Varela E, Konyalian V, Stamos MJ, et al. Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery. Annals Surg. 2007;246(6):1021-7.

Downloads

Published

2024-09-25

Issue

Section

Original Research Articles